First author | Total admissions (N) | Suspected Malaria (N) | Malaria patients (N) | Age of patients | Sex of patients (female) | Malaria testing | Appropriate treatment | ||
---|---|---|---|---|---|---|---|---|---|
Proportion | 95% CI | Proportion | 95% CI | ||||||
Abiodun [31] | 3511 | 1807 | 431 | NR | NR | 0.47 | 0.44–0.49 | 0.43 | 0.38–0.47 |
Cohen [22] | 24,756 | 24,756 | 7340 | 23.2 | 49% | 0.56 | 0.53–0.58 | 0.59 | 0.56–0.61 |
Garg [34] | 3087 | 3087 | 825 | NR | NR | 0.72 | 0.69–0.74 | 0.71 | 0.65–0.77 |
Aguemon [15] | NR | NR | 313 | NR | 52.4% | 0.59 | 0.49–0.69 | 0.54 | 0.44–0.64 |
Bonful [18] | 2519 | 2519 | 158 | 3.2 | NR | 0.4 | 0.36–0.45 | 0.92 | 0.84–0.96 |
Worges [17] | 286 | 286 | 39 | under 5: 35% | 60% | 0.37 | 0.21–0.56 | 0.30 | 0.17–0.48 |
Zurovac [13] | NR | 1224 | 366 | NR | NR | 0.88 | 0.85–0.93 | 0.56 | 0.51–0.61 |
Gallay [14] | 6391 | 248 | 140 | NR | NR | 0.69 | 0.64–0.73 | 0.52 | 0.435–0.60 |
Plucinski [12] | 1224 | 790 | 293 | NR | NR | 0.49 | 0.46–0.54 | 0.43 | 0.38–0.48 |
Namuyinga [19] | 2096 | 1427 | 530 |  ≥ 5: 71% | NR | 0.75 | 0.69–0.82 | 0.92 | 0.84–0.98 |
Pulford [35] | NR | 771 | 122 |  ≤ 15: 64% | 53% | 0.77 | 0.67–0.85 | 0.65 | 0.54–0.75 |
Zurovac [16] | 226 | 226 | NR | NR | NR | 0.35 | 0.23–0.48 | 0.68 | 0.53–0.75 |
Landman [36] | 459 | 257 | 11 |  < 5: 27% | 68% | 0.59 | 0.52–0.65 | 0.55 | 0.45–0.65 |
Steinhardt [37] | 2019 | 1747 | 629 |  ≥ 5: 29% | NR | 0.48 | 0.43–0.52 | 0.67 | 0.59–0.76 |
Rowe [38] | NR | 177 | 59 | NR | NR | 0.30 | 0.18–0.43 | 0.49 | 0.33–0.64 |
Total | 46,574 | 39,322 | 11,256 | 60%: ≥ 5 | 57% | 0.57 | 49–65 | 0.60 | 53–67 |